| Primary |
| Staphylococcal Infection |
12.7% |
| Infection |
10.7% |
| Panniculitis |
8.0% |
| Erysipelas |
6.7% |
| Pneumonia |
6.7% |
| Tonsillitis |
6.0% |
| Antibiotic Therapy |
5.3% |
| Pneumonia Aspiration |
5.3% |
| Tooth Infection |
5.3% |
| Device Related Infection |
4.7% |
| Abscess |
4.0% |
| Antiinflammatory Therapy |
3.3% |
| Prophylaxis |
3.3% |
| Pyrexia |
3.3% |
| Sepsis |
3.3% |
| Acne |
2.7% |
| Analgesic Therapy |
2.7% |
| Anaesthesia Procedure |
2.0% |
| Arthritis Bacterial |
2.0% |
| Blood Pressure |
2.0% |
|
| Drug Eruption |
9.6% |
| Rash |
9.6% |
| Urticaria |
8.5% |
| Pyrexia |
6.4% |
| Renal Impairment |
6.4% |
| Renal Failure |
5.3% |
| Syncope |
5.3% |
| Vomiting |
5.3% |
| Anaphylactic Shock |
4.3% |
| Dyspnoea |
4.3% |
| Gastrointestinal Haemorrhage |
4.3% |
| Tachycardia |
4.3% |
| Trismus |
4.3% |
| Angioedema |
3.2% |
| Blood Glucose Increased |
3.2% |
| Interstitial Lung Disease |
3.2% |
| Pharyngeal Oedema |
3.2% |
| Platelet Count Decreased |
3.2% |
| Rhabdomyolysis |
3.2% |
| Thrombocytopenia |
3.2% |
|
| Secondary |
| Product Used For Unknown Indication |
19.8% |
| Pneumonia |
8.0% |
| Osteomyelitis |
7.6% |
| Endocarditis Staphylococcal |
7.3% |
| Epilepsy |
6.6% |
| Pain |
5.6% |
| Drug Use For Unknown Indication |
5.2% |
| Pyrexia |
4.9% |
| Bronchitis |
3.5% |
| Skin Infection |
3.5% |
| Allogenic Bone Marrow Transplantation Therapy |
3.1% |
| Atrial Fibrillation |
3.1% |
| Depression |
3.1% |
| Hypertension |
2.8% |
| Infection |
2.8% |
| Pharyngitis |
2.8% |
| Sepsis |
2.8% |
| Septic Arthritis |
2.8% |
| Abscess |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
|
| Rash |
10.8% |
| Skin Exfoliation |
7.7% |
| Drug Eruption |
6.2% |
| Pyrexia |
6.2% |
| Sepsis |
6.2% |
| Upper Respiratory Tract Inflammation |
6.2% |
| White Blood Cell Count Increased |
6.2% |
| Interstitial Lung Disease |
4.6% |
| Mixed Liver Injury |
4.6% |
| Pneumonia |
4.6% |
| Rash Maculo-papular |
4.6% |
| Renal Failure |
4.6% |
| Toxic Skin Eruption |
4.6% |
| Urine Output Decreased |
4.6% |
| Cholangitis |
3.1% |
| Erythema Multiforme |
3.1% |
| Gastrointestinal Haemorrhage |
3.1% |
| Hepatic Function Abnormal |
3.1% |
| Hepatocellular Damage |
3.1% |
| Pruritus |
3.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
41.2% |
| Diffuse Large B-cell Lymphoma |
16.4% |
| Product Used For Unknown Indication |
8.1% |
| Prophylaxis |
7.9% |
| Hypertension |
3.6% |
| Pneumonia |
2.2% |
| Multiple Myeloma |
2.1% |
| Hiv Infection |
2.0% |
| Pain |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Infection |
1.7% |
| Non-small Cell Lung Cancer |
1.4% |
| Acne |
1.4% |
| Insomnia |
1.3% |
| Acquired Immunodeficiency Syndrome |
1.3% |
| Immunosuppression |
1.3% |
| Constipation |
1.2% |
| Extradural Abscess |
1.2% |
| Premedication |
1.1% |
| Sepsis |
1.1% |
|
| Respiratory Failure |
9.6% |
| Pyrexia |
7.2% |
| Renal Disorder |
7.2% |
| White Blood Cell Count Decreased |
7.2% |
| Septic Shock |
6.4% |
| Thrombocytopenia |
6.4% |
| Febrile Neutropenia |
5.6% |
| Renal Failure |
5.6% |
| Blood Sodium Decreased |
4.8% |
| Drug Eruption |
4.8% |
| Rash |
4.8% |
| Rhabdomyolysis |
4.0% |
| Sepsis |
4.0% |
| Interstitial Lung Disease |
3.2% |
| Mediastinal Abscess |
3.2% |
| Pneumonia |
3.2% |
| Rectal Ulcer |
3.2% |
| Tenderness |
3.2% |
| Thirst |
3.2% |
| Venoocclusive Liver Disease |
3.2% |
|
| Interacting |
| Infection |
75.0% |
| Anxiety Disorder |
25.0% |
|
| Drug Interaction |
57.1% |
| Postmenopausal Haemorrhage |
28.6% |
| Rhabdomyolysis |
14.3% |
|
